Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Language
Publication year range
1.
AIDS Care ; 30(5): 623-633, 2018 05.
Article in English | MEDLINE | ID: mdl-29411628

ABSTRACT

Human immunodeficiency virus (HIV-1) infection and acquired immunodeficiency syndrome (AIDS) lead to neurocognitive disorders; however, there is still much knowledge to be gained regarding HIV-associated neurocognitive disorders. The purpose of this study was to assess the cognitive performance, instrumental activities of daily living, depression, and anxiety in patients with asymptomatic HIV-1 infections compared with seronegative participants without neurocognitive impairment. We studied a sample consisted of 60 patients with asymptomatic HIV-1 infections and 60 seronegative participants without neurocognitive impairment from the city of Barranquilla, Colombia, with a mean age of 36.07 years. A protocol of neuropsychological and psychopathological tests was applied to the participants. The group of patients with asymptomatic HIV infections significantly underperformed on tasks that assessed global cognitive screening, attention span, learning, phonemic verbal fluency, auditory-verbal comprehension, information processing speed, cognitive flexibility, and motor skills compared to the group of seronegative participants. No significant differences were found in memory, visual confrontation naming, vocabulary, inhibition, and instrumental activities of daily living. Additionally, the patients with asymptomatic HIV-1 infection had a higher anxiety index than the seronegative participants, but no significant difference was found in depression. A correlation was found between depression and anxiety. In conclusion, the patients with asymptomatic HIV-1 infection had lower cognitive performances than the seronegative participants in the cognitive functions mentioned above and more anxiety but still performed the instrumental activities of daily living.


Subject(s)
Asymptomatic Diseases/psychology , Cognition Disorders/virology , HIV Infections/psychology , HIV-1 , Mental Processes , Activities of Daily Living , Adult , Anxiety/virology , Attention , Cognition , Depression/virology , Female , HIV Infections/virology , Humans , Learning , Male , Middle Aged , Motor Skills , Neuropsychological Tests , Reaction Time
2.
J Alzheimers Dis ; 55(3): 1195-1205, 2017.
Article in English | MEDLINE | ID: mdl-27792014

ABSTRACT

BACKGROUND: Recent studies report increases in neural activity in brain regions critical to episodic memory at preclinical stages of Alzheimer's disease (AD). Although electroencephalography (EEG) is widely used in AD studies, given its non-invasiveness and low cost, there is a need to translate the findings in other neuroimaging methods to EEG. OBJECTIVE: To examine how the previous findings using functional magnetic resonance imaging (fMRI) at preclinical stage in presenilin-1 E280A mutation carriers could be assessed and extended, using EEG and a connectivity approach. METHODS: EEG signals were acquired during resting and encoding in 30 normal cognitive young subjects, from an autosomal dominant early-onset AD kindred from Antioquia, Colombia. Regions of the brain previously reported as hyperactive were used for connectivity analysis. RESULTS: Mutation carriers exhibited increasing connectivity at analyzed regions. Among them, the right precuneus exhibited the highest changes in connectivity. CONCLUSION: Increased connectivity in hyperactive cerebral regions is seen in individuals, genetically-determined to develop AD, at preclinical stage. The use of a connectivity approach and a widely available neuroimaging technique opens the possibility to increase the use of EEG in early detection of preclinical AD.


Subject(s)
Alzheimer Disease/physiopathology , Alzheimer Disease/psychology , Brain Mapping , Brain/pathology , Memory, Episodic , Neural Pathways/physiology , Adult , Alzheimer Disease/epidemiology , Alzheimer Disease/genetics , Asymptomatic Diseases/epidemiology , Asymptomatic Diseases/psychology , Brain/physiopathology , Colombia/epidemiology , Diffusion Magnetic Resonance Imaging , Electroencephalography , Entropy , Female , Functional Laterality , Humans , Male , Mutation/genetics , Neuropsychological Tests , Photic Stimulation , Presenilin-1/genetics , Young Adult
3.
Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; Braz. J. Psychiatry (São Paulo, 1999, Impr.);38(2): 113-120, Apr.-June 2016. tab
Article in English | LILACS | ID: lil-784298

ABSTRACT

Objective: To study anxiety as a variable of the mid- and long-term psychological impact of pre-symptomatic testing for three autosomal dominant late-onset disorders – Huntington’s disease (HD), Machado-Joseph disease (MJD) and familial amyloid polyneuropathy (FAP) TTR V30M – in a Portuguese sample. Methods: This cross-sectional study included 203 participants: 170 (83.7%) underwent pre-symptomatic testing for FAP, 29 (14.3%) for HD, and 4 (2%) for MJD. Of the 203 participants, 73 (36.0%) were asymptomatic carriers, 29 (14.5%) were symptomatic carriers, 9 (4.5%) were diagnosed with FAP and had a liver transplant, and 89 (44.5%) were non-carriers. Most were women (58.1%) and married (66.5%). The anxiety variable was assessed using the Zung Self-Rating Anxiety Scale (SAS). Results: The anxiety scores were higher for symptomatic carriers and for those who underwent psychological support consultations over the years. For symptomatic carriers, the mean scores were superior to 40 points, which reflects clinical anxiety. Conclusion: Although it was not possible to differentiate between the mid- and long-term psychological impacts, this study supports the conclusion that the proximity to the age of symptoms onset might be a trigger for anxiety.


Subject(s)
Humans , Male , Female , Adult , Aged , Anxiety/diagnosis , Huntington Disease/psychology , Machado-Joseph Disease/psychology , Amyloid Neuropathies, Familial/psychology , Asymptomatic Diseases/psychology , Anxiety/classification , Anxiety/psychology , Portugal , Time Factors , Cross-Sectional Studies , Predictive Value of Tests , Surveys and Questionnaires , Huntington Disease/diagnosis , Machado-Joseph Disease/diagnosis , Amyloid Neuropathies, Familial/diagnosis , Middle Aged
4.
Braz J Psychiatry ; 38(2): 113-20, 2016 Feb 05.
Article in English | MEDLINE | ID: mdl-26870910

ABSTRACT

OBJECTIVE: To study anxiety as a variable of the mid- and long-term psychological impact of pre-symptomatic testing for three autosomal dominant late-onset disorders - Huntington's disease (HD), Machado-Joseph disease (MJD) and familial amyloid polyneuropathy (FAP) TTR V30M - in a Portuguese sample. METHODS: This cross-sectional study included 203 participants: 170 (83.7%) underwent pre-symptomatic testing for FAP, 29 (14.3%) for HD, and 4 (2%) for MJD. Of the 203 participants, 73 (36.0%) were asymptomatic carriers, 29 (14.5%) were symptomatic carriers, 9 (4.5%) were diagnosed with FAP and had a liver transplant, and 89 (44.5%) were non-carriers. Most were women (58.1%) and married (66.5%). The anxiety variable was assessed using the Zung Self-Rating Anxiety Scale (SAS). RESULTS: The anxiety scores were higher for symptomatic carriers and for those who underwent psychological support consultations over the years. For symptomatic carriers, the mean scores were superior to 40 points, which reflects clinical anxiety. CONCLUSION: Although it was not possible to differentiate between the mid- and long-term psychological impacts, this study supports the conclusion that the proximity to the age of symptoms onset might be a trigger for anxiety.


Subject(s)
Amyloid Neuropathies, Familial/psychology , Anxiety/diagnosis , Asymptomatic Diseases/psychology , Huntington Disease/psychology , Machado-Joseph Disease/psychology , Adult , Aged , Amyloid Neuropathies, Familial/diagnosis , Anxiety/classification , Anxiety/psychology , Cross-Sectional Studies , Female , Humans , Huntington Disease/diagnosis , Machado-Joseph Disease/diagnosis , Male , Middle Aged , Portugal , Predictive Value of Tests , Surveys and Questionnaires , Time Factors
5.
PLoS Negl Trop Dis ; 6(6): e1705, 2012.
Article in English | MEDLINE | ID: mdl-22720112

ABSTRACT

INTRODUCTION: Human T-cell lymphotropic virus type 1 (HTLV-1) infection is intractable and endemic in many countries. Although a few individuals have severe symptoms, most patients remain asymptomatic throughout their lives and their infections may be unknown to many health professionals. HTLV-1 can be considered a neglected public health problem and there are not many studies specifically on patients' needs and emotional experiences. OBJECTIVE: To better understand how women and men living with HTLV-1 experience the disease and what issues exist in their healthcare processes. METHODS: A qualitative study using participant observation and life story interview methods was conducted with 13 symptomatic and asymptomatic patients, at the outpatient clinic of the Emilio Ribas Infectious Diseases Institute, in Sao Paulo, Brazil. RESULTS AND DISCUSSION: The interviewees stated that HTLV-1 is a largely unknown infection to society and health professionals. Counseling is rare, but when it occurs, focuses on the low probability of developing HTLV-1 related diseases without adequately addressing the risk of infection transmission or reproductive decisions. The diagnosis of HTLV-1 can remain a stigmatized secret as patients deny their situations. As a consequence, the disease remains invisible and there are potentially negative implications for patient self-care and the identification of infected relatives. This perception seems to be shared by some health professionals who do not appear to understand the importance of preventing new infections. CONCLUSIONS: Patients and medical staff referred that the main focus was the illness risk, but not the identification of infected relatives to prevent new infections. This biomedical model of care makes prevention difficult, contributes to the lack of care in public health for HTLV-1, and further perpetuates the infection among populations. Thus, HTLV-1 patients experience an "invisibility" of their complex demands and feel that their rights as citizens are ignored.


Subject(s)
HTLV-I Infections/epidemiology , HTLV-I Infections/psychology , Adult , Asymptomatic Diseases/psychology , Brazil/epidemiology , Female , HTLV-I Infections/transmission , Human T-lymphotropic virus 1/isolation & purification , Humans , Interviews as Topic , Male , Middle Aged , Patient Acceptance of Health Care , Social Stigma
SELECTION OF CITATIONS
SEARCH DETAIL